Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Spectral Medical Inc T.EDT

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  EDTXF

Spectral Medical Inc is a Phase III company developing the first theranostic treatment for patients with septic shock.
Price: $0.75 | Change: $-0.01 | %Change: -1.32%
Volume: 219,187 | Day High/Low: 0.78/0.74 | 52 Week High/Low: 0.82/0.26
View modes: 
4.5 stars

Article Medical Device Daily

Firm develops personalized approach for treating Sepsis By OMAR FORD Medical Device Daily Staff Writer Last year, the Global Sepsis Alliance said that sepsis is a medical emergency beyond...read more
0 stars

RE:I think thats the whole point ....

Good point DSMB won't approve for interim analysis if they don't see any value ....so definetly they agree that spectral might be able (Possibilty) to show the improved results with lesser population....read more
0 stars

I think thats the whole point ....

The Anaylst reports are great for a point of reference and can guide you with some caution and prudence. However ...... the whole idea behind the PMA going forward with the approval of the DMSB is...read more
0 stars

RE:RE:Today's Zack's Update

Ooops, forgot to close the quote.  Napodano said this, "Thus, valuation is attractive at today's price."  Just to be clear, everything after that is my own opinion not his.  rate and reply
4 stars

RE:Today's Zack's Update

Napodano was definitely correct to include this statement, "Thus, valuation is attractive at today's price.  I am of the opinion that any purchase below a buck is a gift from the trading gods.  And...read more
0 stars

RE:Today's Zack's Update

I like the Zacks guy, he's level-headed and a decent writer.  However, he's severely underestimating that these trial recommendations are coming from an independent DSMB.  Of course investors should...read more
0 stars

RE:RE:RE:RE:Zacks Coverage--Today

Don't forget that the DSMB did a trial specific analysis for the first 184 patients and they surely saw something good in results from patients with MODS>9. That's why they proposed the additional...read more
0 stars

RE:RE:RE:Zacks Coverage--Today

If there is an 80 percent chance of approval, then this analysis is seriously flawed with the multiple layers of discounting applied for risk - it should only be applied once, globally for the entire...read more
0 stars

RE:Today's Zack's Update

ur are correct tech need to wait for updates from spectral...but zack has put longs on dilema whether to buy now or wait for selloff to add more..I am hoping spectral will somehow get an approval in...read more
0 stars

Today's Zack's Update

Pretty good update for a free report..  Their original report when they had recommended Spectral was also detailed and informative.. Their biggest concern seems to be at current enrollment rate, they...read more
0 stars

RE:RE:RE:RE:Zacks Coverage--Today

41%  rate and reply
0 stars

RE:RE:RE:Zacks Coverage--Today

How effective would this product have to be to have statistical significance with their small sample size?   Calling all statisticians.   30%-40%-50% reduction in mortality?  rate and reply
0 stars

RE:RE:Zacks Coverage--Today

Seems they have weighed both postive and negatives::::: on postive side  On the contrary, if the interim analysis does show statistical separation in favor of the Toraymyxin column, we believe the...read more
0 stars

RE:Zacks Coverage--Today

Nice coverage but seems the statistical calculation doesnot favor a 2015 approval as spectral will need close to 230 patients for success whivh will take them into end of 2016 ....thats zacks take...read more
3.5 stars

Zacks Coverage--Today

http://finance.yahoo.com/news/edt-spectral-medical-preparing-release-193000831.html  rate and reply
0 stars

RE:Cormack Report on Spectral Medical Inc

Important nugget Diamond ! This is the key to early commercialization... It's very reassuring to know that the FDA is prepared to accept the modular PMA http://www.fda.gov/MedicalDevices...read more
5 stars

Cormack Report on Spectral Medical Inc

Here is a very bullish report Cormacks did on Spectral Medical Inc. in November 2014. It's a bit dated in that it states in the report they are not even sure if the FDA will accept the PMA or whats...read more
5 stars

More Info on Spectral Medical Inc. for new investors ....

Just a few more paragraphs I pulled from Spectral Medicals Management Discussion and Analysis for anyone interested .... all this info is available on www.sedar.com where all public company filings...read more
4.5 stars

RE:news

Thanks for posting the news release.  I recommend going to Sedar.com and going through the MD&A  ( Management Discussion & Analysis ). I picked out probably the two most important paragraphs, but any...read more
0 stars

Seems markets is realizing the true potential

Atlast after several years the true potential is being realized still seems way undervalued but market will valuate it considering both the risks and  potential...should be in upward of $2...JMHO do...read more